» Articles » PMID: 8124786

Coronary Flow Reserve Calculated from Pressure Measurements in Humans. Validation with Positron Emission Tomography

Overview
Journal Circulation
Date 1994 Mar 1
PMID 8124786
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Experimental studies have shown that fractional flow reserve (defined as the ratio of maximal achievable flow in a stenotic area to normal maximal achievable flow) can be calculated from coronary pressure measurements only. The objectives of this study were to validate fractional flow reserve calculation in humans and to compare this information with that derived from quantitative coronary angiography.

Methods And Results: Twenty-two patients with an isolated, discrete proximal or mid left anterior descending coronary artery stenosis and normal left ventricular function were studied. Relative myocardial flow reserve, defined as the ratio of absolute myocardial perfusion during maximal vasodilation in the stenotic area to the absolute myocardial perfusion during maximal vasodilation (adenosine 140 micrograms.kg-1 x min-1 intravenously during 4 minutes) in the contralateral normally perfused area, was assessed by 15O-labeled water and positron emission tomography (PET). Myocardial and coronary fractional flow reserve were calculated from mean aortic, distal coronary, and right atrial pressures recorded during maximal vasodilation. Distal coronary pressures were measured by an ultrathin, pressure-monitoring guide wire with minimal influence on the trans-stenotic pressure gradient. Minimal obstruction area, percent area stenosis, and calculated stenosis flow reserve were assessed by quantitative coronary angiography. There was no difference in heart rate, mean aortic pressure, or rate-pressure product during maximal vasodilation during PET and during catheterization. Percent area stenosis ranged from 40% to 94% (mean, 77 +/- 13%), myocardial fractional flow reserve from 0.36 to 0.98 (mean, 0.61 +/- 0.17), and relative flow reserve from 0.27 to 1.23 (mean, 0.60 +/- 0.26). A close correlation was found between relative flow reserve obtained by PET and both myocardial fractional flow reserve (r = .87) and coronary fractional flow reserve obtained by pressure recordings (r = .86). The correlations between relative flow reserve obtained by PET and stenosis measurements derived from quantitative coronary angiography were markedly weaker (minimal obstruction area, r = .66; percent area stenosis, r = -.70; and stenosis flow reserve, r = .68).

Conclusions: Fractional flow reserve derived from pressure measurements correlates more closely to relative flow reserve derived from PET than angiographic parameters. This validates in humans the use of fractional flow reserve as an index of the physiological consequences of a given coronary artery stenosis.

Citing Articles

Contemporary Functional Coronary Angiography: An Update.

Bennett J, Chandrasekhar S, Woods E, McLean P, Newman N, Montelaro B Future Cardiol. 2024; 20(14):755-778.

PMID: 39445463 PMC: 11622791. DOI: 10.1080/14796678.2024.2416817.


Diagnostic performance of quantitative perfusion cardiac magnetic resonance imaging in patients with prior coronary artery disease.

Hoek R, Borodzicz-Jazdzyk S, van Diemen P, Somsen Y, W de Winter R, Jukema R Eur Heart J Cardiovasc Imaging. 2024; 26(2):207-217.

PMID: 39382154 PMC: 11781829. DOI: 10.1093/ehjci/jeae262.


Current and Future Applications of Computational Fluid Dynamics in Coronary Artery Disease.

Candreva A, De Nisco G, Lodi Rizzini M, DAscenzo F, De Ferrari G, Gallo D Rev Cardiovasc Med. 2024; 23(11):377.

PMID: 39076179 PMC: 11269074. DOI: 10.31083/j.rcm2311377.


Rb and [O]HO myocardial perfusion PET imaging: a prospective head to head comparison.

Krakauer M, Ismail A, Talleruphuus U, Henriksen A, Lonsdale M, Rasmussen I J Nucl Cardiol. 2023; 30(6):2790-2802.

PMID: 37789106 PMC: 10682292. DOI: 10.1007/s12350-023-03372-7.


Impact of cardiac history and myocardial scar on increase of myocardial perfusion after revascularization.

Jukema R, W de Winter R, Hopman L, Driessen R, van Diemen P, Appelman Y Eur J Nucl Med Mol Imaging. 2023; 50(13):3897-3909.

PMID: 37561140 PMC: 10611874. DOI: 10.1007/s00259-023-06356-4.